PRICE T ROWE ASSOCIATES INC /MD/ - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$10.0%22,6970.0%0.00%
Q4 2022$1
-99.9%
22,6970.0%0.00%
Q3 2022$1,000
-50.0%
22,6970.0%0.00%
Q2 2022$2,000
-50.0%
22,6970.0%0.00%
Q1 2022$4,000
-69.2%
22,6970.0%0.00%
Q4 2021$13,000
-27.8%
22,6970.0%0.00%
Q3 2021$18,000
-25.0%
22,6970.0%0.00%
Q2 2021$24,000
+71.4%
22,697
+42.5%
0.00%
Q1 2021$14,00015,9310.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$651,0000.02%
Altium Capital Management LP 133,333$77,0000.02%
Granite Point Capital Management, L.P. 133,332$77,0000.01%
AQR Arbitrage LLC 45,832$447,0000.01%
Radcliffe Capital Management, L.P. 33,333$325,0000.01%
COWEN AND COMPANY, LLC 178,347$103,0000.01%
CVI Holdings, LLC 118,333$69,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 333,333$193,0000.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$36,0000.00%
683 Capital Management, LLC 200,000$116,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders